Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
385 participants
OBSERVATIONAL
2025-11-03
2026-01-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Urdu Translation, Validity and Reliability of Quick Disabilities of Arm, Shoulder & Hand (QuickDASH)
NCT06191705
Urdu Translation and Validation of Michigan Hand Outcome Questionnaire
NCT05931133
Upper Extremity Function, Shoulder Position Sense and Disability Level İn Patients With Multiple Sclerosis
NCT03846336
Reliability and Validity of Urdu Translation of Western Ontario Shoulder Instability Index
NCT05440500
Wrist Position Sense in Individuals With Multiple Sclerosis
NCT06232850
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A cross-sectional research design will be used, involving adults aged 18-45 years diagnosed with upper limb functional limitations. Participants will complete both the Urdu and English DASH questionnaires to evaluate reliability and validity. Reliability will be assessed through internal consistency (Cronbach's alpha) and test-retest stability (ICC), while validity will be examined using expert scoring (CVI) and correlation with the original instrument. Data analysis will follow standard psychometric testing procedures using SPSS.
The expected outcome is a reliable, valid tool for assessing upper extremity disability in Urdu-speaking populations. This will improve clinical assessment, enhance patient communication, and support broader inclusion in rehabilitation research and practice.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Data will be collected from experienced physiotherpist
All participants (Aviane)
Data will be collected from patients having upper limb pain or disability
data collection
Data will be collected from patients having upper limb pain or disbility
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
All participants (Aviane)
Data will be collected from patients having upper limb pain or disability
data collection
Data will be collected from patients having upper limb pain or disbility
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
Patients with congenital deformities. Refusal to give informed consent.
18 Years
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bahria University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rabia Khan
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University
Karachi, Sindh, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Basakci Calik B, Demir P, Gur Kabul E, Caglayan BC, Keskin A, Karasu U. Validity and Reliability of the Turkish Version of the DASH-TR Questionnaire in Rheumatoid Arthritis Patients, Based on Rasch Analysis. Int J Rheum Dis. 2022 Aug;25(8):851-860. doi: 10.1111/1756-185X.14358. Epub 2022 Jun 6.
Puentes Gutierrez AB, Garcia Bascones M, Jimenez Diaz F, Cuena Boy R, Puentes Gutierrez R. [Validity and reliability of DASH questionnaire in women who suffer from lymphedema as a side effect of a breast cancer treatment]. Rehabilitacion (Madr). 2023 Jul-Sep;57(3):100780. doi: 10.1016/j.rh.2022.100780. Epub 2023 Feb 3. Spanish.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BUHS-ERC#001\DPT\25
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.